EoPancreas: New Diabetes Patch Pump and CGM System in Development

FDA has granted "Breakthrough Device Designation" to South Korean company EoFlow, developing a tubeless patch-pump based Automated Insulin Delivery (AID) system.
FDA has granted Breakthrough Device Designation to South Korean company EoFlow, developing a tubeless patch-pump based Automated Insulin Delivery (AID) system.

Quarterly Update Diabetes Technology

Bionic Pancreas Improves A1C and Time in Range

Diabetes Café (@Diabetesto) / X

Insulin Patch Pumps: Their Development and Future in Closed-Loop Systems

Quarterly Update Diabetes Technology

Quarterly Update Diabetes Technology

December update on closed-loop systems

Insulet, Abbott earn EU nod for artificial pancreas system

Shop CGM & Pump Underpatches today - Protect your CGM - Trusted by thousands like you – Type One Style

Diabetes Insulin Pumps & Patches: What Are They

Diabetes Management with Insulin Pumps and CGMs (Continuous Glucose Monitors)